Principal Financial Group’s Amneal Pharmaceuticals AMRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $12.1M | Buy |
972,529
+817,652
| +528% | +$11M | 0.01% | 1231 |
|
|
2025
Q4 | $1.95M | Buy |
154,877
+46,433
| +43% | +$531K | ﹤0.01% | 1844 |
|
|
2025
Q3 | $1.09M | Sell |
108,444
-617
| -0.6% | -$5.54K | ﹤0.01% | 1910 |
|
|
2025
Q2 | $882K | Buy |
109,061
+11,351
| +12% | +$85.6K | ﹤0.01% | 1906 |
|
|
2025
Q1 | $819K | Buy |
97,710
+875
| +0.9% | +$7.3K | ﹤0.01% | 1873 |
|
|
2024
Q4 | $767K | Buy |
96,835
+8,213
| +9% | +$68.9K | ﹤0.01% | 1903 |
|
|
2024
Q3 | $737K | Sell |
88,622
-4,944
| -5% | -$38.7K | ﹤0.01% | 1888 |
|
|
2024
Q2 | $594K | Sell |
93,566
-16,519
| -15% | -$105K | ﹤0.01% | 1913 |
|
|
2024
Q1 | $667K | Buy |
110,085
+59,671
| +118% | +$336K | ﹤0.01% | 1930 |
|
|
2023
Q4 | $306K | Sell |
50,414
-4,018
| -7% | -$17.9K | ﹤0.01% | 2057 |
|
|
2023
Q3 | $230K | Buy |
54,432
+5,092
| +10% | +$19K | ﹤0.01% | 2127 |
|
|
2023
Q2 | $153K | Sell |
49,340
-12,025
| -20% | -$25.6K | ﹤0.01% | 2221 |
|
|
2023
Q1 | $85.3K | Sell |
61,365
-8,867
| -13% | -$17.7K | ﹤0.01% | 2317 |
|
|
2022
Q4 | $140K | Buy |
70,232
+16,339
| +30% | +$36.6K | ﹤0.01% | 2248 |
|
|
2022
Q3 | $109K | Sell |
53,893
-38,209
| -41% | -$107K | ﹤0.01% | 2319 |
|
|
2022
Q2 | $293K | Sell |
92,102
-11,465
| -11% | -$41.5K | ﹤0.01% | 2188 |
|
|
2022
Q1 | $432K | Sell |
103,567
-34,474
| -25% | -$153K | ﹤0.01% | 2152 |
|
|
2021
Q4 | $661K | Sell |
138,041
-60,068
| -30% | -$299K | ﹤0.01% | 2064 |
|
|
2021
Q3 | $1.06M | Sell |
198,109
-282
| -0.1% | -$1.42K | ﹤0.01% | 1995 |
|
|
2021
Q2 | $1.02M | Buy |
198,391
+60,520
| +44% | +$344K | ﹤0.01% | 2034 |
|
|
2021
Q1 | $928K | Buy |
137,871
+5,252
| +4% | +$29.1K | ﹤0.01% | 2008 |
|
|
2020
Q4 | $606K | Sell |
132,619
-39,660
| -23% | -$176K | ﹤0.01% | 2067 |
|
|
2020
Q3 | $668K | Buy |
172,279
+58,688
| +52% | +$251K | ﹤0.01% | 1955 |
|
|
2020
Q2 | $541K | Buy |
113,591
+19,724
| +21% | +$81.2K | ﹤0.01% | 1951 |
|
|
2020
Q1 | $327K | Buy |
93,867
+3,121
| +3% | +$13.2K | ﹤0.01% | 1942 |
|
|
2019
Q4 | $437K | Buy |
90,746
+22,656
| +33% | +$78.8K | ﹤0.01% | 1974 |
|
|
2019
Q3 | $198K | Buy |
68,090
+6,209
| +10% | +$21.7K | ﹤0.01% | 2145 |
|
|
2019
Q2 | $444K | Buy |
61,881
+42,423
| +218% | +$434K | ﹤0.01% | 1986 |
|
|
2019
Q1 | $276K | Buy |
19,458
+2,973
| +18% | +$39.3K | ﹤0.01% | 2058 |
|
|
2018
Q4 | $223K | Buy |
16,485
+3,843
| +30% | +$69.3K | ﹤0.01% | 2104 |
|
|
2018
Q3 | $281K | Buy |
+12,642
| New | +$266K | ﹤0.01% | 2085 |
|
Other funds holding AMRX
TGA
VPM
RCMNY
VCM
